Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock, located in Tehran, is a subsidiary of Tamin Pharmaceutical Investment Company (TPICO) from SSIC SHASTA Group. Established in 1997, the company is a leading producer of Active Pharmaceutical Ingredients (API) in Iran. They specialize in manufacturing Narcotics and Non-narcotics in two main categories: API and semi-finished products such as pellets and DC. In 2017, the company began producing finished dosage products including syrup, tablets, and capsules to expand their business and cater to the domestic pharmaceutical companies and Middle Eastern markets. Temad Co. currently operates 21 active production lines and offers over 120 pharmaceutical products, including narcotics, non-narcotics, LVHV, corton, injections, and medicine for opioid dependency. Their products adhere to international standards such as GMP and WHO. With a team of 570 experienced and innovative personnel, including chemists, chemical engineers, and specialist pharmacists, Temad Co. aims to achieve long-term goals and maintain a significant presence in the global pharmaceutical market. They supply their products to both the domestic market in Iran and export 25 products to 52 countries across 5 continents.
Legal Address
28Km Of Karaj Special Road, In Front Of The Metro Atmosphere Station, Garmadreh City, Fadak Alley, No. 2, Ground Floor
Tehran; Tehran;
Postal Code: 3164816478
Contact Details: Purchase the Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock report to view the information.
Website: http://www.temad.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service